University of California, San Francisco
San Francisco, CA
Mack Roach III
Department of Radiation Oncology and Urology, University of California San Francisco, San Francisco, CA, USA.
Mack Roach III is Professor of Radiation Oncology and Urology and formerly Chairman of the Department of Radiation Oncology at University of California San Francisco. Dr. Roach obtained his medical degree from Stanford University. His research interests have focused on the use of various forms of radiation in the management of prostate cancer (PCa) and Health Disparities related to Race. Dr. Roach been an active in several clinical trials and chaired two large prospective phase III randomised trials (RTOG 9413 and RTOG 0924). Both involved the treatment of men with locally advanced PCa and have attempted to shed light on the role of prophylactic pelvic nodal radiation. He also contributed as a senior author to the development of guidelines for PCa treatment planning, published by the American College of Radiology. Professor Roach is a member of many medical societies including the American Society of Clinical Oncology, the ASTRO, and the RTOG. He acted as an advisor for the National Cancer Institute (NCI) IMRT Working Group and American Joint Commission for Cancer Staging, the American Cancer Society (ACS) Task Force for Cancer Screening Guidelines for prostate cancer and the NCI Concept Evaluation Panel (Prostate Cancer Phase III Trials) and previously as Medical/Scientific Officer Chair of the Health Systems Group for the California Division of the ACS. Professor Roach previously serves on the NCI National Cancer Advisory Board (appointed by President Obama in 2012).
Disclosures:
Advances in Prostate Reirradiation: Integrating Current Evidence into Everyday Clinical Practice
Sunday, September 29, 2024
4:47 PM – 4:59 PM ET
Tuesday, October 1, 2024
11:25 AM – 11:30 AM ET